Influence of serum and soluble CD25 (sCD25) on regulatory and effector T-cell function in hepatocellular carcinoma.
about
Special role of Foxp3 for the specifically altered microRNAs in Regulatory T cells of HCC patients.Effect of pregnancy on anti-HEV antibody titres, plasma cytokines and the corresponding gene expression levels in the PBMCs of patients presenting with self-recovering clinical and subclinical hepatitis EAnticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25.Neutrophil-lymphocyte ratio predicts overall and recurrence-free survival after liver transplantation for hepatocellular carcinoma.Altered serum cytokine signature in common variable immunodeficiencyImmune modulation of effector CD4+ and regulatory T cell function by sorafenib in patients with hepatocellular carcinoma.The emerging role of anti-CD25 directed therapies as both immune modulators and targeted agents in cancer.Hepatitis B surface antigen could contribute to the immunopathogenesis of hepatitis B virus infection.Guardian and selective killer: the versatile functions of TLR3 in hepatocellular carcinomaDendritic Cells Pulsed with Exosomes in Combination with PD-1 Antibody Increase the Efficacy of Sorafenib in Hepatocellular Carcinoma Model.IL-2 and Beyond in Cancer Immunotherapy.Soluble CD25 is increased in patients with sepsis-induced acute kidney injury.
P2860
Q33906361-F5C0D404-B114-467A-ACD1-5AE4EAD7E53EQ33988977-17D30908-C061-42B2-9656-6FACC8430F23Q36293343-DAC6115D-0EF7-4630-80AE-AA5279BBBBA1Q36756063-20E92AEC-DD72-4954-B3C0-F5180DB87940Q36909039-CA2DF78C-9FB5-4E00-AAF8-4D681DE67B2DQ37393627-21908BCD-B2C1-49C8-B715-161E92EEB83AQ39338052-0A673949-D5E1-4D41-9644-2D5AEED54B62Q41982541-11FE8DAC-2ADC-45D0-B110-0839CDA2A1FCQ42386394-91A9637E-EEDE-419A-94FD-BE534D8B2B57Q49480626-D0238EE5-FD07-44A0-83B4-5F534BC415B4Q50004232-B5D76CB8-5B34-4500-BE1B-CBE5C30FB87AQ53061642-D6C11E9B-5203-4D85-9DB9-1C14B4B87FD9
P2860
Influence of serum and soluble CD25 (sCD25) on regulatory and effector T-cell function in hepatocellular carcinoma.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Influence of serum and soluble ...... n in hepatocellular carcinoma.
@en
Influence of serum and soluble CD25
@nl
type
label
Influence of serum and soluble ...... n in hepatocellular carcinoma.
@en
Influence of serum and soluble CD25
@nl
prefLabel
Influence of serum and soluble ...... n in hepatocellular carcinoma.
@en
Influence of serum and soluble CD25
@nl
P2093
P2860
P1476
Influence of serum and soluble ...... n in hepatocellular carcinoma.
@en
P2093
D R Nelson
M A Atkinson
P2860
P304
P356
10.1111/J.1365-3083.2010.02427.X
P577
2010-10-01T00:00:00Z